Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025)

Lantheus Holdings (LNTH) posted quarterly Liabilities from Discontinued Operations of 22468000.0 for Q4 2025, down 21.35% quarter-over-quarter from 28566000.0 in Q3 2025.

Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has reported Liabilities from Discontinued Operations for 3 consecutive years, with 22468000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 22468000.0; the TTM figure through Dec 2025 stood at 22468000.0 (changed N/A YoY), while the FY2025 annual figure was 22468000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations declined to 22468000.0 in Q4 2025 per LNTH's latest filing, from 28566000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 29845000.0 in Q2 2025 and bottomed at 22468000.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 22.47 Mn
Dec 31, 2025 22.47 Mn
Sep 30, 2025 28.57 Mn
Sep 30, 2025 28.57 Mn
Jun 30, 2025 29.85 Mn
Jun 30, 2025 29.85 Mn
Dec 31, 2020 1.79 Mn
Dec 31, 2020 1.79 Mn
Dec 31, 2015 1.72 Mn
Dec 31, 2015 1.72 Mn